Company

Henlius Reports 97.2% YOY Revenue Growth in Q1 2023, Highlighted by Strong Sales of Hanquyou and HaiSiZhuang

Policy / Regulatory

Hainan Introduces Management Regulations for Urgently Needed Import Drugs and Devices in Boao Lecheng

CompanyDrug

Minghui Pharmaceutical’s MH004 Cream Shows Positive Results in Atopic Dermatitis Phase II Trial

CompanyDrug

AffaMed Therapeutics Gets NMPA Approval for Phase III Dextenza Study in Post-Ophthalmic Surgery

Medical DevicePolicy / Regulatory

NHC Proposes Updates to Access Standards for Class A and B Medical Equipment

CompanyDrug

Harbour Biomed to Present Early Clinical Data for CTLA-4 Antibody Combo at AACR 2023

CompanyDrug

RemeGen’s Disitamab Vedotin (RC48) Clears for Phase I Study in HER2-Positive Tumors

CompanyDrug

Junshi Biosciences’ JS401 Receives NMPA Approval for Hyperlipidemia Clinical Trial

CompanyDeals

Jiangxi Jemincare Group Secures Exclusive Rights to Promote MabPharm’s Biosimilar CMAB007

CompanyDeals

Zhejiang Dian Diagnostics Partners with Meituan for Digital Healthcare Services Expansion

CompanyDrug

Ocumension Therapeutics’ Zerviate NDA Accepted for Review by China’s NMPA

CompanyDeals

Pfizer and Sinopharm Expand Partnership to Enhance Drug Distribution and Lifecycle Solutions